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"Never before has the pace of change been so great or 
so widespread; nothing will ever be the same again. 
What an opportunity!" 
Kathleen L. Wishner 
Things will never be the same again. 
Diabetes 1996; 45: 541-543 
 
• In her paper "Tilings will never be the same again" Dr 
Kathleen L. Wishner (Lilly Corporate Center, Indianapolis, IN) 
quoted Alvin Toffler's book Future Shock written in 1970. 
Toffler defined "future shock" as a time phenomenon, a prod- 
uct of the greatly accelerated change in society. The scientific 
research itself is a demonstration of this accelerated change. In 
particular, data systematized by Davidoff et al (1) in this vol- 
ume of Biomedical Reviews indicate the change in the under- 
standing of the nature and origin of Ley dig cells of the human 
testis. 
See Review on page 11 
Paracrine, autocrine and intracrine mechanisms are obviously 
important in all organs since they enable the efficient coordi- 
nation of functions of the different cell types that constitute 
these organs. The testis needs such mechanisms not only be- 
cause of the presence of many different cell types, e.g. Leydig 
cells, Sertoli cells, peritubular myofibroblasts, germ cells, and 
immune cells, but also because of the changing requirements 
to coordinate the functions of these cells in a cyclic and time- 
dependent manner (1,2). Furthermore, all these events have 
to be coordinated with different body functions. This is accom- 
plished by an interaction between paracrine and endocrine sig- 
nalling, the Leydig cell being a component of the hypotha- 
lamic-pituitary-gonadal axis. 
Using antibodies directed against a large panel of neuronal 
and neuroendocrine marker substances, Davidoff etal (1) pro- 
vide conceptual evidence strongly suggestive of a dual, endo- 
crine and neuroendocrine nature and of a neural crest origin 
of human Leydig cells. Thus these authors propose Leydig 
cells as a new member of the diffuse neuroendocrine system. 
Recently, the bidirectional interaction between the neuroen- 
docrine and immune systems is a subject of intensive research 
(3-8). The reasons for this are: (/) cytokines as well as neu- 
rotrophins and neuropeptides are mediators of both neural and 
immune responses, (/'/') neuroendocrine and immune cells have 
common receptors for hormones, cytokines, neurotrophins, and 
neurotransmitters, and (/'//') immune cells produce over 20 dif- 
ferent neuroendocrine peptides (5,8) and neurotrophins. Also, 
cytokines exert pronounced endocrine effects on the hypotha- 
lamic-pituitary-adrenocortical axis (6,8) and the hypothalamic- 
pituitary-gonadal axis (4, 6, 9). 
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Collectively, these findings (3-8), Davidoff and colleagues' data 
(1 and Refs therein) and the recent results about Leydig cell- 
immune cell interactions (9-16) suggest that a local neuroen- 
docrine-immune link may exist within the testis. The Leydig 
cell-macrophage interaction in rodent testis was described (10- 
12), suggesting a role of testicular macrophages in both regu- 
lation of Leydig cell functions and promotion of Leydig cell 
development. Yet another part of this testicular neuro- 
endocrine-immune cross-talk is the possible involvement of 
Leydig cells in estrogen-induced mast cell proliferation in the 
rat testis, where Leydig cells are proposed to regulate intersti- 
tial mast cells proliferation via negative paracrine way (13- 
15). Indeed, Leydig cell express and/or secrete regulatory 
modules (1, 4, 6, 9), with both activating and inhibitory ef- 
fects on testicular immune cells. For example, the Leydig cell- 
derived substance P, vasoactive intestinal polypeptide and (3- 
endorphin (1) may affect mast cell activity (16, 17) and T cell 
proliferation (6, 8). Recently we observed mast cell increase 
in the heart after suppressing the Leydig cells by estrogen treat- 
ment of newborn rats indicating that Leydig cells also influ- 
ence extratesticular immunocytes via negative endocrine way 
(15). Not surprisingly, mast cells and Leydig cells were de- 
scribed to proliferate simultaneously in the testis after selec- 
tive Leydig cell destruction by ethane dimethane sulfonate (11, 
see also 1 and Refs 45, 65 therein). Hence, it worths to exam- 
ine whether mast cell-derived neurotrophins, e.g. nerve growth 
factor (18) and leukemia inhibitory factor (19), exert some 
influence on Leydig cells. 
Altogether these data would suggest that the Leydig cell-im- 
mune cell link is an example of neuroendocrine-immune com- 
munication in testis (Fig. 1). We realize that the rapidly devel- 
oping tale of this interaction warns us that generalization may 
be premature, and it is better to conclude that there is an op- 
portunity here for (/) additional data (31), (/';') new interpreta- 
tions of hitherto unexplained, "neurotrophic" facts (32-34, see 
also 1 and Refs 218, 219 therein), and (Hi) broadening the in- 
ternational scientific community involved in this research field 
  
 
Figure 1. Suggested bidirectional paracrine links bet\veen neuroendocrine and immune cells in the testis. A possible cross- 
talk behveen Leydig and immune cells via neuroendocrine peptides produced by these cells (1, 5, 8), herein depicted /?- 
endorphin (fi-END) (16, 17) only, should also be considered. 
* effects of nitric oxide (NO) on immune cells (20) may also be depicted in Fig. 11 of Davidoff et al (21), illustrating 
schematically the possible functional significance of Leydig cell-produced NO. 
** as found for nerve growth factor receptors (1), we suggest that the receptors for these neurotrophic cytokines (19, 22, 
23) as well as some purinoceptors (24, 25) may also be considered in further studies of Leydig cells. 
*** note that interleukin-1 (IL-1) stimulates Leydig cell proliferation and inhibits steroidogenesis (6), and induces hista- 
mine release from mast cells (26) and neuropeptide Yexpression in Leydig cells (1, their Ref 137; see also 1, their Ref 119 
for Leydig cell-derived IL-1). 
Other abbreviations and respective references: SP - substance P (1, 16, 17, 19), VIP - vasoactive intestinal peptide (6, 16, 
17), MT - melatonin (27), T - testosterone (7), CA - catecholamines (28), SCF - stem cell factor (mast cell growth factor, c- 
kit ligand) (22), LIF - leukemia inhibitory factor (19, 23), TNF-a-tumor necrosis factor-a (10, 19, 29), 5-HT - 5-hydrox- 
ytryptamine (serotonin) (30), ATP - adenosine 5'~triphosphate (24, 25), A - adenosine (24, 25). 
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(35). These may have some therapeutic potentials for diseases 
of the male reproductive organs (1, 30, 36, 37). 
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